KIAA1797 Activators
KIAA1797 Activators are a collection of chemical compounds that facilitate the functional activity of KIAA1797 by engaging distinct signaling pathways. Compounds like Forskolin, IBMX, and Dibutyryl cAMP exert their effects by enhancing intracellular cAMP levels, which subsequently activate protein kinase A (PKA). This activation of PKA can lead to phosphorylation of proteins that are part of KIAA1797's signaling network, thus promoting its activity. Similarly, Epigallocatechin gallate can indirectly benefit KIAA1797's pathways by inhibiting kinases which would otherwise engage in competitive signaling, thus freeing pathways to enhance KIAA1797's function. The lipid signaling molecule Sphingosine-1-phosphate activates sphingosine kinase, which has the potential to intersect with KIAA1797-involved pathways, leading to its activation.
The activity of KIAA1797 is also influenced by calcium signaling modulators such as A23187, a calcium ionophore that increases intracellular calcium levels, and Thapsigargin, which inhibits the SERCA pump leading to a similarcalcium effect. Both compounds can activate calcium-dependent signaling cascades that are likely to facilitate KIAA1797's functional enhancement. Furthermore, the direct activation of protein kinase C (PKC) by PMA may alter various signaling pathways, some of which might be responsible for the activation of KIAA1797. Staurosporine, despite its general kinase inhibition profile, might paradoxically lead to the activation of KIAA1797 by selectively disrupting inhibitory signals within its signaling network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate substrates that may be involved in the same signaling pathways as KIAA1797, leading to its functional enhancement. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents cAMP breakdown. This raises cAMP levels and subsequently activates PKA, potentially phosphorylating proteins within KIAA1797's signaling cascade, resulting in its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, a cAMP analog, directly activates PKA. PKA activation could lead to phosphorylation events within the signaling pathways involving KIAA1797, thereby enhancing its functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is known to inhibit certain types of kinases. By inhibiting competitive signaling pathways, it may indirectly enhance signaling pathways that activate KIAA1797. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine kinase, which may interact with signaling pathways that include KIAA1797, leading to its downstream activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels. This can activate calcium-dependent signaling pathways that may indirectly lead to the enhancement of KIAA1797's function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, which leads to an increase in cytosolic calcium levels and may activate calcium-dependent pathways that could enhance KIAA1797's function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. Activation of PKC can lead to the modulation of signaling pathways that intersect with those involving KIAA1797, potentially leading to its activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, but it may selectively activate signaling pathways by lifting the inhibition of kinases that suppress pathways involving KIAA1797. | ||||||